CALLAN JMB INC. 8-K

What Happened
Callan JMB Inc. announced on June 29, 2026 that Nasdaq’s Listing Qualifications Department sent a notice saying the company no longer meets Nasdaq Capital Market’s $1.00 minimum bid price requirement under Rule 5550(a)(2) based on the closing bid for the last 30 consecutive business days. The notice has no immediate delisting effect and the company’s common stock continues to trade on Nasdaq under the symbol “CJMB.”

Key Details

• Notice received: June 29, 2026.
• Compliance period: initial 180-calendar-day cure period through December 28, 2026.
• To regain compliance: closing bid must be ≥ $1.00 for at least 10 consecutive business days (Nasdaq may require up to ~20 consecutive days).
• If not cured, the company may be eligible for a second 180-day period only if it meets market value of publicly held shares and other initial listing standards (except the minimum bid), and notifies Nasdaq it will seek cure (potentially via a reverse stock split).
• The company says it will monitor the stock price and consider options (including a reverse split) and included standard forward‑looking statement disclosures.

Why It Matters
This filing alerts investors that CJMB faces potential delisting risk if its share price does not recover. While trading is uninterrupted for now, failure to meet the $1.00 threshold within the stated compliance windows could lead to delisting proceedings or require corporate action (e.g., reverse stock split) to restore compliance. Investors should monitor the company’s share price, any announced corporate actions, and subsequent Nasdaq communications or appeals.